**Question:** Pethidine should not be given with

A. Naloxone
B. Midazolam
C. Sodium bicarbonate
D. Dexamethasone

**Core Concept:**
Pethidine, also known as morphine, is an opioid analgesic medication used for pain relief. It binds to opioid receptors in the central nervous system to modulate pain signals and produce analgesia. When administered, pethidine can interact with other drugs, causing adverse effects or reducing its effectiveness.

**Why the Correct Answer is Right:**
Pethidine should not be given with naloxone (A) because naloxone is a strong antagonist of opioid receptors. When administered together, naloxone competitively binds to opioid receptors, overcoming the analgesic effects of pethidine and causing a rapid reversal of its analgesic action.

**Why Each Wrong Option is Incorrect:**

A. Naloxone (Option A): As explained above, naloxone is an opioid receptor antagonist, which reverses the effects of pethidine.
B. Midazolam (Option B) is a benzodiazepine, which is a different class of medication with different pharmacodynamics and pharmacokinetics. While both are used for sedation, they do not interact in a way that would negate pethidine's analgesic effects.
C. Sodium bicarbonate (Option C) is commonly used to neutralize acidosis in patients with respiratory acidosis. In this context, it does not interact with pethidine, and there is no pharmacological rationale for combining them.
D. Dexamethasone (Option D) is a synthetic glucocorticoid used for its anti-inflammatory and immunosuppressive effects. While it can be used in combination with pethidine, the interaction between them is not as straightforward as with naloxone and does not negate pethidine's analgesic effects.

**Core Concept:**
Pethidine, a synthetic opioid, is a potent analgesic used for pain relief in clinical practice. It binds to opioid receptors, primarily mu-opioid receptors, and inhibits the transmission of pain signals, thus producing analgesia.

**Why the Correct Answer is Right:**
Naloxone (Option A) is a potent antagonist of both mu- and kappa-opioid receptors. When naloxone is administered, it competes with pethidine for binding to opioid receptors, leading to a reversal of pethidine's analgesic effect.

**Why Each Wrong Option is Incorrect:**

B. Midazolam (Option B) is a benzodiazepine with sedative properties. Although it can be used in combination with pethidine, their interactions are not as straightforward as with naloxone, making Option B incorrect.

C. Sodium bicarbonate (Option C) is used to neutralize acidosis in patients with respiratory acidosis. This option does not have a direct pharmacological interaction with pethidine and is not relevant to